NANOXPLORE INC (GRA.CA) Stock Fundamental Analysis
Canada - TSX:GRA - CA63010G1000 - Common Stock
2.66 CAD
0 (0%)
Taking everything into account, GRA scores 3 out of 10 in our fundamental rating. GRA was compared to 28 industry peers in the Chemicals industry. While GRA seems to be doing ok healthwise, there are quite some concerns on its profitability. GRA is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year GRA has reported negative net income.
In the past year GRA had a positive cash flow from operations.
GRA had negative earnings in each of the past 5 years.
In multiple years GRA reported negative operating cash flow during the last 5 years.
1.2 Ratios
GRA has a Return On Assets (-6.40%) which is comparable to the rest of the industry.
GRA has a Return On Equity of -9.76%. This is comparable to the rest of the industry: GRA outperforms 53.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.4% | ||
| ROE | -9.76% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of GRA (18.55%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of GRA has grown nicely.
The Profit Margin and Operating Margin are not available for GRA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 18.55% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y60.11%
GM growth 5Y11.17%
2. Health
2.1 Basic Checks
GRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GRA remains at a similar level compared to 1 year ago.
Compared to 5 years ago, GRA has more shares outstanding
GRA has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 5.36 indicates that GRA is not in any danger for bankruptcy at the moment.
GRA's Altman-Z score of 5.36 is fine compared to the rest of the industry. GRA outperforms 78.57% of its industry peers.
GRA has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.16, GRA is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.36 |
ROIC/WACCN/A
WACC7.67%
2.3 Liquidity
A Current Ratio of 1.93 indicates that GRA should not have too much problems paying its short term obligations.
The Current ratio of GRA (1.93) is better than 60.71% of its industry peers.
GRA has a Quick Ratio of 1.37. This is a normal value and indicates that GRA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.37, GRA is in the better half of the industry, outperforming 60.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
GRA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
Looking at the last year, GRA shows a decrease in Revenue. The Revenue has decreased by -0.83% in the last year.
The Revenue has been growing by 15.63% on average over the past years. This is quite good.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-0.83%
Revenue growth 3Y11.74%
Revenue growth 5Y15.63%
Sales Q2Q%-16.89%
3.2 Future
GRA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.96% yearly.
The Revenue is expected to grow by 23.27% on average over the next years. This is a very strong growth
EPS Next Y27.06%
EPS Next 2Y47.25%
EPS Next 3Y50.87%
EPS Next 5Y36.96%
Revenue Next Year2.43%
Revenue Next 2Y22.59%
Revenue Next 3Y32.31%
Revenue Next 5Y23.27%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
GRA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GRA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as GRA.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 184.01 |
4.3 Compensation for Growth
A more expensive valuation may be justified as GRA's earnings are expected to grow with 50.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.25%
EPS Next 3Y50.87%
5. Dividend
5.1 Amount
No dividends for GRA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:GRA (10/22/2025, 7:00:00 PM)
2.66
0 (0%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners12.57%
Inst Owner ChangeN/A
Ins Owners7.38%
Ins Owner ChangeN/A
Market Cap453.82M
Revenue(TTM)128.92M
Net Income(TTM)-9660000
Analysts76
Price Target3.99 (50%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.49%
Min EPS beat(2)0.99%
Max EPS beat(2)33.99%
EPS beat(4)2
Avg EPS beat(4)-8.63%
Min EPS beat(4)-53.98%
Max EPS beat(4)33.99%
EPS beat(8)4
Avg EPS beat(8)-15.47%
EPS beat(12)7
Avg EPS beat(12)-23.14%
EPS beat(16)8
Avg EPS beat(16)-55.45%
Revenue beat(2)0
Avg Revenue beat(2)-9.74%
Min Revenue beat(2)-14.65%
Max Revenue beat(2)-4.83%
Revenue beat(4)0
Avg Revenue beat(4)-7.21%
Min Revenue beat(4)-14.65%
Max Revenue beat(4)-4.31%
Revenue beat(8)0
Avg Revenue beat(8)-6.97%
Revenue beat(12)3
Avg Revenue beat(12)-3.72%
Revenue beat(16)5
Avg Revenue beat(16)-1.61%
PT rev (1m)3.99%
PT rev (3m)3.99%
EPS NQ rev (1m)-466.6%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-18.16%
EPS NY rev (3m)-405.6%
Revenue NQ rev (1m)-30.83%
Revenue NQ rev (3m)-30.83%
Revenue NY rev (1m)-11.41%
Revenue NY rev (3m)-24.78%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 3.52 | ||
| P/FCF | N/A | ||
| P/OCF | 76.27 | ||
| P/B | 4.58 | ||
| P/tB | 5.33 | ||
| EV/EBITDA | 184.01 |
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.03
OCFY1.31%
SpS0.76
BVpS0.58
TBVpS0.5
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.4% | ||
| ROE | -9.76% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 18.55% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y60.11%
GM growth 5Y11.17%
F-Score5
Asset Turnover0.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 6.43 | ||
| Cap/Depr | 127.27% | ||
| Cap/Sales | 10.86% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 239.23% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 5.36 |
F-Score5
WACC7.67%
ROIC/WACCN/A
Cap/Depr(3y)102.65%
Cap/Depr(5y)101.42%
Cap/Sales(3y)8.35%
Cap/Sales(5y)8.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y27.06%
EPS Next 2Y47.25%
EPS Next 3Y50.87%
EPS Next 5Y36.96%
Revenue 1Y (TTM)-0.83%
Revenue growth 3Y11.74%
Revenue growth 5Y15.63%
Sales Q2Q%-16.89%
Revenue Next Year2.43%
Revenue Next 2Y22.59%
Revenue Next 3Y32.31%
Revenue Next 5Y23.27%
EBIT growth 1Y19.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year201.78%
EBIT Next 3Y112.63%
EBIT Next 5YN/A
FCF growth 1Y-50.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.56%
OCF growth 3YN/A
OCF growth 5YN/A